Tubeless Insulin Pump Market Size

 Tubeless Insulin Pump Market Size

Tubeless Insulin Pump Market size was valued at around USD 1.6 billion in 2022 and is projected to reach over USD 8.9 billion by 2032. The increasing prevalence of diabetes is a significant driver for the market.

To get key market trends

  Download Free Sample

According to the International Diabetes Federation (IDF), in 2021, the global population having diabetes mellitus (DM) was estimated to be 463 million in 2019 and is going to increase to 700 million by 2045. The increasing number of diabetes cases around the globe can be attributable to factors such as genetics, aging population, and lifestyle among others. Moreover, the ongoing technological advancements along with incremental healthcare expenditure associated with diabetes are further contributing to the market progress.

Tubeless insulin pump refers to a medical device designed to help manage diabetes by delivering a continuous supply of insulin to a patient's body without the need for traditional insulin injections. Tubeless insulin pumps are designed to be worn directly on the body and do not have external tubing.

However, the high cost associated with advanced tubeless insulin pumps can cause a challenge and hinder market growth in the projected timeframe. For instance, the cost of an adult insulin delivery system ranges between USD 4,500 to USD 6,500 and may vary according to the technology and sensors used in these devices. The high cost of these devices may limit acceptance by the diabetic population, affecting manufacturers’ ability to invest in the technology. Thus, the aforementioned factors are anticipated to impede the market expansion.